Published in Pharmacogenetics on October 01, 1992
Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochem J (1994) 1.13
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2. Curr Drug Metab (2008) 1.09
A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J Med Genet (1997) 0.97
Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro. Biochem J (1994) 0.92
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. Br J Pharmacol (2014) 0.87
Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity. Br J Clin Pharmacol (2003) 0.86
Arylamine N-acetyltransferase activity in human cultured cell lines. Biochem J (1993) 0.81
A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology. Breast Cancer Res (2005) 0.80
NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant. BMC Med Genet (2004) 0.78
NAT2 genetic variations among South Indian populations. Hum Genome Var (2014) 0.75
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
The covalent-binding reaction of complement component C3. Biochem J (1981) 2.80
Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol (1986) 2.64
Purification of human C3b inactivator by monoclonal-antibody affinity chromatography. Biochem J (1982) 2.53
Elastase-induced experimental aneurysms in rats. Circulation (1990) 2.50
Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest (2000) 2.42
Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev (2000) 2.20
Phenotyping of human complement component C4, a class-III HLA antigen. Biochem J (1986) 2.10
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin. Biochem J (1981) 1.78
Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat Struct Biol (2000) 1.72
Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics (2000) 1.71
Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2). Biochem J (1984) 1.51
An optimal control model for maximum-height human jumping. J Biomech (1990) 1.49
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest (1988) 1.48
N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem Pharmacol (1991) 1.44
Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics (1987) 1.44
Pattern of degradation of human complement fragment, C3b. FEBS Lett (1981) 1.42
Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant (1999) 1.40
Monoclonal antibodies against the complement control protein factor H (beta 1 H). Biosci Rep (1983) 1.40
Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg (1974) 1.35
Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J Bacteriol (1999) 1.31
Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM (1996) 1.31
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet (1995) 1.30
Metabolic polymorphisms and cancer susceptibility. Cancer Surv (1995) 1.26
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J (2002) 1.24
Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood (1990) 1.20
Expression of arylamine N-acetyltransferase in human intestine. Gut (1998) 1.16
Use of a specific antiserum for renin detection in human kidney. J Histochem Cytochem (1980) 1.15
Urothelial neoplasia with plasmacytoid morphology. Histopathology (2006) 1.15
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev (2001) 1.14
Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochem J (1994) 1.13
[Crohn's disease of the colon. IV. Cytologic and ultrastructural study of the plasmocytic and epithelio-giant-cellular inflammatory infiltrates]. Sem Hop (1970) 1.13
Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry (1986) 1.12
Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes. Mutagenesis (2001) 1.12
Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. Carcinogenesis (2002) 1.11
Surgical management of right colon diverticulitis. Dis Colon Rectum (1992) 1.09
Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol Microbiol (2001) 1.09
Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. Microbiology (2001) 1.09
hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int J Cancer (2000) 1.09
Letter: Alpha-chain disease cured with antibiotics. Br Med J (1975) 1.07
Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res (1988) 1.05
Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum Pathol (1985) 1.04
Identification of tissues and cells producing erythropoietin in the anemic mouse. Contrib Nephrol (1988) 1.03
Structure and mechanism of arylamine N-acetyltransferases. Curr Top Med Chem (2006) 1.03
Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol (1995) 1.02
Drugs that induce systemic lupus erythematosus inhibit complement component C4. Lancet (1984) 1.02
Renin biosynthesis by human tumoral juxtaglomerular cells. Evidences for a renin precursor. J Clin Invest (1984) 1.02
Arylamine N-acetyltransferase in human red blood cells. Biochem Pharmacol (1992) 1.01
Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics (2001) 1.00
Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. Biochem Pharmacol (1995) 1.00
Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet (2000) 0.99
Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. Pharmacogenetics (1997) 0.99
Arylamine N-acetyltransferases - of mice, men and microorganisms. Trends Pharmacol Sci (2001) 0.99
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer (2001) 0.99
Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J Histochem Cytochem (1996) 0.99
Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet Cell Genet (1997) 0.98
Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J (2003) 0.97
Transforming growth factor-beta1 and lung allograft fibrosis. Eur J Cardiothorac Surg (1998) 0.97
Enzymic assay of C3b receptor on intact cells and solubilized cells. Biochem J (1983) 0.97
A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes. Eye (Lond) (2002) 0.96
Long-time quantum simulation of the primary charge separation in bacterial photosynthesis. Proc Natl Acad Sci U S A (1996) 0.96
Hydralazine binds covalently to complement component C4. Different reactivity of C4A and C4B gene products. FEBS Lett (1985) 0.95
Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab Invest (1989) 0.95
Binding of fluid-phase complement components C3 and C3b to human lymphocytes. Biochem J (1981) 0.94
Hydrogenase activity in Paracoccus denitrificans. Partial purification and interaction with the electron transport chain. Biochimie (1978) 0.94
Comparison of the membrane-bound and detergent-solubilised hydrogenase from paracoccus denitrificans. Isolation of the hydrogenase. Biochim Biophys Acta (1979) 0.94
Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease. Neuroreport (1998) 0.94
Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene (2012) 0.94
Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology (1998) 0.93
Purification, characterization, and crystallization of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium. Protein Expr Purif (1998) 0.93
N-Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast. Pharmacogenetics (2001) 0.93
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase. Int J Tuberc Lung Dis (2000) 0.92
Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro. Biochem J (1994) 0.92
Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity. Pharmacogenetics (2000) 0.91
Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations. Clin Genet (2012) 0.91
Complement receptors and related complement control proteins. Biochem Soc Symp (1986) 0.91
Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol (1986) 0.91
Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis. Microbiology (2001) 0.91
Immunohistochemical characterization of renin-containing cells in the human juxtaglomerular apparatus during embryonal and fetal development. Lab Invest (1981) 0.91
Drug metabolising N-acetyltransferase activity in human cell lines. Biochim Biophys Acta (1991) 0.90
[Histochemical and histoenzymatic study of experimental myocardial infarction in the rat by temporary and permanent ligation of the left coronary artery (author's transl)]. Virchows Arch A Pathol Anat Histol (1975) 0.90
Abnormalities of renin-containing cells in human glomerular and vascular renal diseases. Kidney Int (1983) 0.89
Systemic sclerosis and cryoglobulinemia. Clin Immunol Immunopathol (1976) 0.89
Effects of chronic dietary fructose with and without copper supplementation on glycaemic control, adiposity, insulin binding to adipocytes and glomerular basement membrane thickness in normal rats. Br J Nutr (1993) 0.89
Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants. Biochem Pharmacol (1998) 0.89
Renin localization in segmental renal hypoplasia. Immunohistochemical demonstration in two cases. Virchows Arch A Pathol Anat Histol (1981) 0.89
The effect of coronary artery reperfusion on the extent of myocardial infarction. Am Heart J (1977) 0.89
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration. Eur Respir J (2009) 0.89
Retinopathy of prematurity. A randomized, prospective trial of transcutaneous oxygen monitoring. Ophthalmology (1987) 0.89
A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. Br J Rheumatol (1996) 0.88
The epidemiology of the acute flank pain syndrome from suprofen. Clin Pharmacol Ther (1989) 0.88
Foreign body asphyxiation--an autopsy study. Am J Med (1999) 0.88
Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch A Pathol Anat Histopathol (1989) 0.88